{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:29:23Z","timestamp":1790890163980,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R41DK138551"],"award-info":[{"award-number":["R41DK138551"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015412","name":"Small Business Technology Transfer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101500","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T20:53:11Z","timestamp":1748638391000},"page":"101500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dose-finding and in vivo safety study of an adipose targeted leptin gene therapy for congenital leptin deficiency"],"prefix":"10.1016","volume":"33","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawfiq","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunchang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya A.","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0322-4985","authenticated-orcid":false,"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101500_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature21365","article-title":"Adipose-derived circulating miRNAs regulate gene expression in other tissues","volume":"542","author":"Thomou","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101500_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41574-019-0230-6","article-title":"The endocrine function of adipose tissues in health and cardiometabolic disease","volume":"15","author":"Scheja","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.omtm.2025.101500_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.omtm.2025.101500_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ibd\/izy331","article-title":"The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease","volume":"25","author":"Mao","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.omtm.2025.101500_bib5","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1172\/JCI129187","article-title":"Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome","volume":"129","author":"Kahn","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101500_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.omtm.2020.09.009","article-title":"Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors","volume":"19","author":"Bates","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101500_bib7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s42255-019-0095-y","article-title":"Leptin and the endocrine control of energy balance","volume":"1","author":"Friedman","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.omtm.2025.101500_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101500_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4158\/EP09154.RA","article-title":"Clinical classification and treatment of congenital and acquired lipodystrophy","volume":"16","author":"Chan","year":"2010","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.omtm.2025.101500_bib10","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review#: Lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2025.101500_bib11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101500_bib12","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1210\/jc.2004-0376","article-title":"Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy","volume":"89","author":"Gibson","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2025.101500_bib13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101500_bib14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40264-014-0226-z","article-title":"Side effects of cytokines approved for therapy","volume":"37","author":"Baldo","year":"2014","journal-title":"Drug Saf."},{"key":"10.1016\/j.omtm.2025.101500_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.omtm.2019.01.008","article-title":"Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors","volume":"12","author":"Buning","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.omtm.2025.101500_bib16","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"AAV vectors: The Rubik's cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101500_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2025.101500_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060361","article-title":"Assessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retina","volume":"8","author":"Charbel Issa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101500_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/mtm.2013.8","article-title":"Adipose tissue insulin receptor knockdown via a new primate-derived hybrid recombinant AAV serotype","volume":"1","author":"Liu","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101500_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2337\/db16-0876","article-title":"Hepatic Expression of Adenovirus 36 E4ORF1 Improves Glycemic Control and Promotes Glucose Metabolism Through AKT Activation","volume":"66","author":"McMurphy","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.omtm.2025.101500_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.omtm.2017.06.002","article-title":"Targeting Visceral Fat by Intraperitoneal Delivery of Novel AAV Serotype Vector Restricting Off-Target Transduction in Liver","volume":"6","author":"Huang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101500_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2019.09.008","article-title":"Adipose PTEN regulates adult adipose tissue homeostasis and redistribution via a PTEN-leptin-sympathetic loop","volume":"30","author":"Huang","year":"2019","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.omtm.2025.101500_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpnec.2020.100013","article-title":"Adipose PTEN acts as a downstream mediator of a brain-fat axis in environmental enrichment","volume":"4","author":"Huang","year":"2020","journal-title":"Compr. Psychoneuroendocrinol."},{"key":"10.1016\/j.omtm.2025.101500_bib24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtm.2020.12.011","article-title":"Visceral adipose tissue-directed FGF21 gene therapy improves metabolic and immune health in BTBR mice","volume":"20","author":"Queen","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101500_bib25","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.4049\/jimmunol.2100313","article-title":"Adipocyte CD1d Gene Transfer Induces T Cell Expansion and Adipocyte Inflammation in CD1d Knockout Mice","volume":"208","author":"Xiao","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtm.2025.101500_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj9109","article-title":"eNAMPT actions through nucleus accumbens NAD(+)\/SIRT1 link increased adiposity with sociability deficits programmed by peripuberty stress","volume":"8","author":"Morato","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2025.101500_bib27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ymthe.2024.02.035","article-title":"Gene therapy approaches for obesity-induced adipose neuropathy: Device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose","volume":"32","author":"Blaszkiewicz","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101500_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/gt.2014.38","article-title":"Targeting adipose tissue via systemic gene therapy","volume":"21","author":"O'Neill","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101500_bib29","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.celrep.2016.01.041","article-title":"Leptin Raises Defended Body Temperature without Activating Thermogenesis","volume":"14","author":"Fischer","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2025.101500_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nmeth.1806","article-title":"A guide to analysis of mouse energy metabolism","volume":"9","author":"Tsch\u00f6p","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2025.101500_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108877","article-title":"Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases","volume":"203","author":"Erichsen","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.omtm.2025.101500_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.physbeh.2017.03.002","article-title":"Leptin resistance and hippocampal behavioral deficits","volume":"176","author":"Van Doorn","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.omtm.2025.101500_bib33","series-title":"Mood and Anxiety Related Phenotypes in Mice","first-page":"1","article-title":"The open field test","author":"Gould","year":"2009"},{"key":"10.1016\/j.omtm.2025.101500_bib34","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2025.101500_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063475","article-title":"The Brain Metabolome Is Modified by Obesity in a Sex-Dependent Manner","volume":"25","author":"Norman","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101500_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1052079","article-title":"Leptin deficiency-caused behavioral change - A comparative analysis using EthoVision and DeepLabCut","volume":"17","author":"Buhler","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtm.2025.101500_bib37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2337\/db23-0444","article-title":"Genetic Analysis of Obesity-Induced Diabetic Nephropathy in BTBR Mice","volume":"73","author":"Keller","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.omtm.2025.101500_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fimmu.2014.00009","article-title":"Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors","volume":"5","author":"Tseng","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101500_bib39","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1128\/JVI.00209-12","article-title":"The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing","volume":"86","author":"Raupp","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101500_bib40","doi-asserted-by":"crossref","first-page":"E4812","DOI":"10.1073\/pnas.1704766114","article-title":"Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion","volume":"114","author":"Tse","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101500_bib41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.omtm.2022.07.018","article-title":"Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper","volume":"26","author":"Yang","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101500_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer","volume":"28","author":"Costa Verdera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101500_bib43","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy","volume":"12","author":"Shimomura","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtm.2025.101500_bib44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.omtm.2022.09.014","article-title":"Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy","volume":"27","author":"Sommer","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101500_bib45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41434-024-00489-3","article-title":"Precision medicine: toward restoring fat with gene therapy in inherited lipodystrophy","volume":"31","author":"Prieur","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101500_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-1-4939-9139-6_23","article-title":"rAAV-Mediated Gene Delivery to Adipose Tissue","volume":"1950","author":"Huang","year":"2019","journal-title":"Methods Mol. Biol."}],"container-title":["Molecular Therapy Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:20:00Z","timestamp":1762615200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125000956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125000956"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101500","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-finding and in vivo safety study of an adipose targeted leptin gene therapy for congenital leptin deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101500"}}